Stocks · Health care · Biological Products, (No Diagnostic Substances)

FENNEC PHARMACEUTICALS INC.

FENC Clue Score47

United States Fiscal year ends December CIK 0001211583 Results filed 24 Mar 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Pierre Sargis Sayad

31 Aug 2026

Chief Medical Officer

Sell

12,000

$12.18

$146.16K

Southpoint Capital Advisors LP

24 Dec 2025

10% owner

Sell indirect

1,000,000

$7.50

$7.50M

Southpoint Capital Advisors LP

18 Nov 2025

10% owner

Sell indirect

19,341

$8.79

$170.05K

Southpoint Capital Advisors LP

17 Nov 2025

10% owner

Sell indirect

85,918

$8.79

$755.19K

Southpoint Capital Advisors LP

14 Nov 2025

10% owner

Sell indirect

160,100

$8.00

$1.28M

Show all 25 transactions →

What was left out

Form 4 filings counted 79

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 3

Sales on a Rule 10b5-1 plan 4

Sales straight out of an exercise 9

Sales at will 5

Transactions with no price 0

Shares from compensation/vesting 464,085

History held since 2 May 2007